Hydrapres Statistics
Total Valuation
Hydrapres has a market cap or net worth of PLN 29.64 million. The enterprise value is 36.26 million.
| Market Cap | 29.64M |
| Enterprise Value | 36.26M |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hydrapres has 52.93 million shares outstanding.
| Current Share Class | 52.93M |
| Shares Outstanding | 52.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 18.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.93 |
| PB Ratio | 6.70 |
| P/TBV Ratio | 6.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.54 |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.87 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 1.92.
| Current Ratio | 0.98 |
| Quick Ratio | 0.56 |
| Debt / Equity | 1.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.41 |
| Interest Coverage | -2.36 |
Financial Efficiency
Return on equity (ROE) is -70.42% and return on invested capital (ROIC) is -16.25%.
| Return on Equity (ROE) | -70.42% |
| Return on Assets (ROA) | -7.69% |
| Return on Invested Capital (ROIC) | -16.25% |
| Return on Capital Employed (ROCE) | -26.68% |
| Revenue Per Employee | 361,459 |
| Profits Per Employee | -54,674 |
| Employee Count | 95 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 4.28 |
Taxes
In the past 12 months, Hydrapres has paid 2,157 in taxes.
| Income Tax | 2,157 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.08% in the last 52 weeks. The beta is -0.16, so Hydrapres's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | +3.08% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 57.96 |
| Average Volume (20 Days) | 1,040 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hydrapres had revenue of PLN 31.81 million and -4.81 million in losses. Loss per share was -0.13.
| Revenue | 31.81M |
| Gross Profit | 552,511 |
| Operating Income | -3.65M |
| Pretax Income | -4.81M |
| Net Income | -4.81M |
| EBITDA | -2.06M |
| EBIT | -3.65M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 1.87 million in cash and 8.48 million in debt, giving a net cash position of -6.61 million or -0.12 per share.
| Cash & Cash Equivalents | 1.87M |
| Total Debt | 8.48M |
| Net Cash | -6.61M |
| Net Cash Per Share | -0.12 |
| Equity (Book Value) | 4.43M |
| Book Value Per Share | 0.12 |
| Working Capital | -322,180 |
Cash Flow
In the last 12 months, operating cash flow was -1.76 million and capital expenditures -165,669, giving a free cash flow of -1.92 million.
| Operating Cash Flow | -1.76M |
| Capital Expenditures | -165,669 |
| Free Cash Flow | -1.92M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 1.74%, with operating and profit margins of -11.46% and -15.13%.
| Gross Margin | 1.74% |
| Operating Margin | -11.46% |
| Pretax Margin | -15.12% |
| Profit Margin | -15.13% |
| EBITDA Margin | -6.47% |
| EBIT Margin | -11.46% |
| FCF Margin | n/a |
Dividends & Yields
Hydrapres does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -16.23% |
| FCF Yield | -6.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hydrapres has an Altman Z-Score of 0.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.66 |
| Piotroski F-Score | 3 |